News | July 09, 2025
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Additional data will be presented on a once-weekly oral combination of islatravir and ulonivirine (ISL/ULO) for HIV-1 treatment
The submission is based on data from the STEP UP and STEP UP T2D clinical trials
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
The company showcased three core programs developed through this platform
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
